Interactive effects of subanesthetic ketamine and subhypnotie lorazepam in humans

Psychopharmacology

Volumn 135, Issue 3, 1998, Pages 213-229

  Krystal, John H ^a,b,c   Karper, Laurence P ^a,b   Bennett, Alexandre ^a,b,d   D'Souza, D Cyril ^a,b   Abi Dargham, Anissa ^a,b   Morrissey, Kristen ^b   Abi Saab, Danielle ^b   Bremner, J Douglas ^a,b   Bowers Jr , Malcolm B ^a,e   Suckow, Raymond F ^f   Stetson, Philip ^g   Heninger, George R ^a,c   Charney, Dennis S ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c Yale University School of Medicine   (United States)

^d WEILL CORNELL MEDICAL CENTER   (United States)

^e Grace Education Building ^*  (United States)

^f NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^g UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Attention; Benzodiazepine; Dissociation; Frontal cortex; GABA; Glutamate; Ketamine; Memory; N methyl D aspartate; Psychosis; Wisconsin Card Sorting Test

Indexed keywords

HYDROCORTISONE; KETAMINE; LORAZEPAM; PLACEBO; PROLACTIN;

ADULT; AMNESIA; ARTICLE; BEHAVIOR DISORDER; BLOOD PRESSURE; CLINICAL TRIAL; COGNITION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; DRUG POTENTIATION; EMOTIONAL STRESS; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEMORY; MOTOR PERFORMANCE; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; PSYCHOSIS; RATING SCALE; SYMPTOM; VOLUNTEER;

ADULT; ANESTHETICS, INTRAVENOUS; ANTI-ANXIETY AGENTS; AROUSAL; ATTENTION; COGNITION; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; FEMALE; HORMONES; HUMANS; KETAMINE; LEARNING; LORAZEPAM; MALE; MEMORY; MENTAL PROCESSES; PSYCHIATRIC STATUS RATING SCALES;

EID: 14444273680     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050503     Document Type: Article

References (109)

1. Agmon A, O'Dowd DK (1992) NMDA receptor-mediated currents are prominent in the thalamocortical synaptic response before maturation of inhibition. J Neurophysiol 68:345-349
2. Åkeson J, Björkman S, Messeter K, Rosén I (1993) Low-dose midazolam antagonizes cerebral metabolic stimulation by ketamine in the pig. Acta Anesthesiol Scand 37:525-531
3. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders 3rd edn, revised. American Psychiatric Association, Washington, DC
4. Anis NA, Berry SC, Burton NR, Lodge D (1983) The dissociative anaesthetics, ketamine and phencyclidine, selectively decrease excitation of central neurons by N-methyl-n-aspartate. Br J Pharmacol 83:179-185
5. Bacopoulos NG, Redmond DE, Roth RH (1979) Serotonin and dopamine metabolites in brain regions and cerebrospinal fluid of a primate species: effects of ketamine and fluphenazine. J Neurochem 32:1215-1218
6. Bell MD, Billington RJ, Becker BR (1985) A scale for the assessment of reality testing: reliability, validity and factorial invariance. J Clin Psychol 53:506-511
7. Benton AL (1968) Differential behavioral effects in frontal lobe disease. Neuropsychologia 6:53-60
8. Borkowski JG, Benton AL, Spreen O (1967) Word fluency and brain damage. Neuropsychologia 5:135-140
9. Bovill JG, Clarke RSJ, Dundee JW, Pandit SK, Moore J (1971) Effect of premedicants and supplements on ketamine anaesthesia. Br J Anesth 43:600-608
10. 9-tetrahydrocannabinol. Biochem Pharmacol 38:2385-2387
11. Bowers MB Jr, Morton JB (1992) Diazepam antagonizes effects on dopamine metabolism produced by PCP receptor agonists. Prog Neuro-Psychopharmacol Biol Psychiatry 16:211-215
12. Bowers MB, Heninger GR, Sternberg D, Meltzer HY (1980) Clinical processes and central dopaminergic activity in psychotic disorders. Commun Psychopharmacol 4:177-188
13. Bresink I, Danysz W, Parson CG, Mutschler E (1995) Different binding affinities of NMDA receptor channel blockers in various brain regions-indication of NMDA receptor heterogeneity. Neuropharmacology 34:533-540
14. Buchanan RW, Heinrichs DW (1989) The neurological evaluation scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res 27:335-350
15. Byrd LD (1987) Effects of phencyclidine and ketamine on cardiovascular activity and temperature in the squirrel monkey. Life Sci 41:7-13
16. Carlsson M, Carlsson A (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia implications for schizophrenia and Parkinson's disease. Trend Neurosci 13:272-276
17. Cartwright PD, Pingel SM (1984) Midazolam and diazepam in ketamine anesthesia. Anesthesia 39:439-442
18. Chapman LJ, Chapman JP, Miller EN (1982) Reliabilities and intercorrelations of eight measures of proneness to psychosis. J Consult Clin Psychol 50:187-195
19. Charney DS, Breier A, Jatlow PI, Heninger GR (1986) Behavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: interactions with yohimbine. Psychopharmacology 88:133-140
20. Charney DS, Woods SW, Goodman WK, Heninger GR (1987) Serotonin function in anxiety. II: effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology 92:14-24
21. Collier BB (1972) Ketamine and the conscious mind. Anaesthesia 27:120-134
22. Coppel DL, Bovill JG, Dunndee JW (1973) The taming of ketamine. Anaesthesia 28:293-296
23. Corssen G, Domino EF (1966) Dissociative anesthesia: further pharmacologic studies and first clinical experience with phencyclidine derivative CI-581. Anesth Analg 45:29-40
24. Deutsch SI, Mastropaolo J, Schwartz BL, Rosse RB, Morihisa JM (1989) A "glutamatergic hypothesis" of schizophrenia: Rationale for pharmacotherapy with glycine. Clin Neuropharmacol 12:1-13
25. Dingledine R, Hynes MA, King GL (1986) Involvement of N-methyl-D-aspartate receptors in epileptiform bursting in the rat hippocampal slice. J Physiol 380:175-189
26. Domino EF, Chodoff P, Corssen G (1965) Pharmacologic effects of CI-581, a new dissociative anesthetic, in man. Clin Pharm Ther 6:279-291
27. Dundee JW, Lilburn JK (1978) Ketamine-lorazepam: attenuation of psychic sequelae of ketamine by lorazepam. Anaesthesia 33: 312-314
28. Dundee JW, Lilburn JK, Nair SG, George KA (1977) Studies of drugs given before anaesthesia. XXVI: Lorazepam. Br J Anesthesia 49:1047-1056
29. Dundee JW, McGowan WAW, Lilburn JK, McKay AC, Hegarty JE (1979) Comparison of the actions of diazepam and lorazepam. Br J Anaesth 51:439-446
30. File SE (1992) Effects of lorazepam on psychomotor performance: a comparison of independent-groups and repeated-measures designs. Pharmacol Biochem Behav 42:761-764
31. File SE, Bond AJ, Lister RG (1982) Interaction between effects of caffeine and lorazepam in performance tests and self-ratings. J Clin Psychopharmacol 2:102-106
32. Fragen RJ, Caldwell N (1976) Lorazepam premedication lack of recall and relief of anxiety. Anesth Analg 55:792-796
33. Freuchen L, Ostergaard J, Kuhl JB, Mikkelsen BO (1976) Reduction of psychotomimetic side effects of Ketalar (ketamine) by Rohypnol (flunitrazepam). A randomized double-blind trial. Acta Anesthesiol Scand 20:97-103
34. Ghoneim MM, Hinrichs JV, Mewaldt SP (1984) Dose-response analysis of the behavioral effects of diazepam. I. Learning and memory. Psychopharmacology 82:291-295
35. Ghoneim MM, Hinrichs JV, Mewaldt SP, Petersen RC (1985) Ketamine: behavioral effects of subanesthetic doses. J Clin Psychopharmacol 5:70-77
36. Giovanni MG, Mutolo D, Bianchi L, Michelassi A, Pepeu G (1994) NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus: a microdialysis study. J Neurosci 14:1358-1365
37. Goldstein K (1949) Frontal lobotomy and impairment of abstract attitude. J Nerv Ment Dis 110:93-111
38. Gordon M (1983) The Gordon diagnostic system. Gordon Systems, DeWitt, N.Y.
39. Gorham DR (1956) A proverbs test for clinical and experimental use. Psychol Rep 2:1-12
40. Grace AA (1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41:1-24
41. Grandison L (1983) Actions of benzodiazepines on the neuroendocrine system. Neuropharmacology 22:1505-1510
42. Hampton RY, Medzihradsky F, Woods JH, Dahlstrom PJ (1982) Stereospecific binding of H-phencyclidine in brain membranes. Life Sci 30:2147-2154
43. Hedlund JL, Vieweg BW (1980) The Brief Psychiatric Rating Scale (BPRS): a comprehensive review. J Operational Psychiatry 11: 48-64
44. Idvall J, Aronsen KF, Stenberg P, Paalzow L (1983) Pharmacodynamic and pharmacokinetic interactions between ketamine and diazepam. Eur J Clin Pharmacol 24:337-343
45. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308
46. Kane J, Honigfeld G, Singer J, Meltzer H, the Clozapine Collaborative Study Group (1988) Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45:789-796
47. Kim JS, Kornhuber HH, Schmid-Burgk W, Holzmüller B (1980) Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 20: 379-382
48. Kluft RF (1987) An update on multiple personality disorder. Hosp Commun Psychiatry 38:363-373
49. Knox JW, Bovill JG, Clarke RSJ, Dundee JW (1970) Clinical studies of induction agents. XXXVI: Ketamine. Br J Anaesth 42:875-885
50. 3H]MK-801 binding sites in the human brain. Brain Res 489:397-399
51. Kothary SP, Zsigmond EK (1977) A double-blind study of the effective antihallucinatory doses of diazepam prior to ketamine anesthesia. Clin Pharmacol Ther 21:108-109
52. Krystal JH, Seibyl JP, Price LH, Woods SW, Heninger GR, Aghajanian GK, Charney DS (1993) m-Chlorophenylpiperazine (MCPP) effects in neuroleptic-free schizophrenic patients: evidence implicating serotonergic systems in the positive symptoms of schizophrenia. Arch Gen Psychiatry 50:624-635
53. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199-214
54. Krystal JH, Bennett A, Bremner JD, Southwick SM, Charney DS (1995) Toward a cognitive neuroscience of dissociation and altered memory functions in post-traumatic stress disorder. In: Friedman MJ, Charney DS, Deutch AY (eds) Neurobiological and clinical consequences of stress: from normal adaptation to PTSD. Raven Press, New York, N.V., pp 239-269
55. Krystal JH, Petrakis IL, Webb E, Cooney NL, Kerper LP, Namanworth S, Trevisan LA, Charney DS (1998) Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. Arch Gen Psychiatry (in press)
56. Kucera H, Francis WN (1967) Computational analysis of present day American English. Brown University Press, Providence, R.I.
57. Lahti AC, Holcomb HH, Medoff DR, Tamminga CA (1995) Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport 6:869-872
58. Leonard BE, Tonge SR (1970) Some effects of a hallucinogenic drug (phencyclidine) on neurohumoral substances. Life Sci 9: 1141-1152
59. Lilburn JK, Dundee JW, Nair SG, Fee JP, Johnston HM (1978) Ketamine sequelae. Evaluation of the ability of various premedicants to attenuate its psychic actions. Anesthesialogy 33:307-311
60. Loh L, Singer L, Morgan M, Moore PH (1972) Influence of diazepam on the emergence reactions following ketamine anesthesia. Can Anaesth Soc J 19:421-425
61. Lovinger DM, White G, Weight FF (1989) Ethanol inhibits NMDA-activated ion currents in hippocampal neurons. Science 243:1721-1724
62. Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelley R (1959) Study of a new schizophrenomimetic drug-sernyl. AMA Arch Neurol Psychiatry 81:363-369
63. Malhotra AK, Pinals DA, Weingartner H, Sirocco K, Missar CD, Pickar D, Breier A (1996) NMDA receptor function and human cognition: the effects of ketamine in healthy subjects. Neuropsychopharmacology 14:301-308
64. Manor D, Behar K, Rothman D, Mason G, Hooten M, Krystal J (1995) Ketamine effects on cortical tricarboxylic acid (TCA) cycle rates and GABA metabolism in rats assessed using magnetic resonance spectroscopy. Presented to the American College of Neuropsychopharmacology 34th Annual Meeting. San Juan, PR, Dec 11-15, p 183
65. McCarthy G, Puce A, Constable RT, Krystal JH, Gore JC, Goldman-Rakic P (1996) Activation of human prefrontal cortex during spatial and object working memory tasks measured by functional MRI. Cereb Cortex 6: 600-611
66. Migály P, Károvitz J, Jakab T, Gaál K (1991) Effects of ketamine anesthesia and stress-reducing psychological methods on surgery patients. In: Spielberger CD, Sarason IG, Kulcsár Z, Van Heck GL (eds) Stress and emotion: anxiety, anger, and curiosity. Hemisphere Publishing, New York, 14:215-224
67. Milner B (1964) Some effects of frontal lobectomy in man. In: Warren JM, Akert K (eds) The frontal granular cortex and behavior. McGraw-Hill, New York, pp 313-334
68. Nutt DJ, Cowen PJ (1987) Diazepam alters brain 5-HT function in man: implications for the acute and chronic effects of benzodiazepines. Psychol Med 17:601-607
69. Oguchi K, Arakawa K, Nelson SR, Samson F (1982) The influence of droperidol, diazepam, and physostigimine on ketamine-induced behavior and brain regional glucose utilization in rat. Anesthesiology 57:353-358
70. Olney JW, Farber NB (1995) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:998-1007
71. Olney JW, Labruyere J, Wang G, Wozniak DF, Price MT, Sesma MA (1991) NMDA antagonist neurotoxicity: mechanism and prevention. Science 254:1515-1518
72. Overall JE, Gorham DR (1962) The brief psychiatric rating scale. Psychol Rep 10:799-812
73. Øye I, Hustveit O, Moberg ER, Pausen O, Skoglund LA (1991) The chiral forms of ketamine as probes for NMDA receptor function in humans. In: Kameyama T, Nabeshima T, Domino EF (eds) NMDA receptor related agents: biochemistry, pharmacology, and behavior. NPP Books, Ann Arbor, Mich., pp 381-389
74. Øye N, Paulsen O, Maurset A (1992) Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 260:1209-1213
75. Pandit SK, Kothary SP, Kumar SM (1980) Low dose intravenous infusion technique with ketamine: amnesic, analgesic and sedative effects in human volunteers. Anaesthesialogy 35: 669-675
76. Pardo JV, Pardo PJ, Janer KW, Raichle (1990) The anterior cingulate cortex mediates processing selection in the Stroop attentional conflict paradigm. Proc Natl Acad Sci USA 87:256-259
77. Restall J, Tully AM, Ward PJ, Kidd AG (1988) Total intravenous anesthesia for military surgery. A technique using ketamine, midazolam and vecuronium. Anesthesia 43:46-49
78. Restall J, Johnston IG, Robinson DN (1990) Flumazenil in ketamine and midazolam anesthesia. Anesthesia 45:938-940
79. Roache JD, Griffiths RR (1987) Lorazepam and meprobamate dose effects in humans:behavioral effects and abuse liability. J Pharmacol Exp Ther 243:978-988
80. Rothman SM, Olney JW (1987) Excitotoxicity and the NMDA receptor. Trend Neurosci 10:299-302
81. Rush CR, Higgins ST, Bickel WK, Hughes JR (1993) Acute effects of triazolam and lorazepam on human learning, performance and subject ratings. J Pharmacol Exp Ther 264:1218-1226
82. Salmaso D, Denes G (1982) Role of the frontal lobes on an attention task:a signal detection analysis. Percept Motor Skills 54:1147-1150
83. Sanders S (1986) The perceptual alteration scale: a scale measuring dissociation. Am J Clin Hypn 29:95-102
84. Siegel RK (1978) Phencyclidine and ketamine intoxication: a study of four populations of recreational users. In: Petersen RC, Stillman RC (eds) Phencyclidine (PCP) abuse: an appraisal, NIDA Research Monograph. Rockville, Md., 21, pp 119-147
85. Slosson RL (1963) Slosson intelligence test (SIT) for children and adults. Slosson Educational Publications, East Aurora, N. Y.
86. Smith DE, Wesson DR, Buxton ME, Seymour R, Kramer HM (1978) The diagnosis and treatment of the PCP abuse syndrome. In: Petersen RC, Stillman RL (eds) Phencyclidine (PCP) abuse: an appraisal. National Institute on Drug Abuse Monographs. US Government Printing Office, Washington D.C., 21, pp 229-240
87. Spitzer RL, Williams JBW, Gibbon M, First MB (1990) Structured clinical interview for DSM-III-R-non-patient edition (SCIDNP, Version 1.0). American Psychiatric Press, Washington, D.C.
88. Steinberg M, Rounsaville B, Cicchetti DV (1990) The structure clinical interview for DSM-III-R dissociative disorder: preliminary report on a new diagnostic instrument. Am J Psychiatry 147: 76-82
89. Stuss DT, Benson DF (1986) The frontal lobes. Raven Press, New York
90. Suzdak PD, Schwartz RD, Skolnick P, Paul SM (1986) Ethanol stimulates g-aminobutyric acid receptor-mediated chloride transport in rat brain synaptoneurosomes. Proc Natl Acad Sci USA 83:4071-4075
91. Thiemann S, Csernansky JG, Berger PA (1987) Rating scales in research: the case of negative symptoms. Psychiatry Res 20:47-55
92. Tobin HA (1982) Low-dose ketamine and diazepam. Arch Otolaryngol 108:439-440
93. Toft P, Romer U (1987) Comparision of midazohim and diazepam to supplement total intravenous anesthesia with ketamine for endoscopy. Can J Anaesth 34:466-469
94. Tucker MR, Hann JR, Phillips CL (1984) Subanesthetic doses of ketamine, diazepam, and nitrous oxide for adult outpatient sedation. J Oral Maxillofac Surg 42:668-672
95. Tuomisto J, Mannisto P (1985) Neurotransmitter regulation of anterior pituitary hormones. Pharmacol Rev 37:249-332
96. Weinberger DR, Berman KF, Zee RF (1986) Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. Arch Gen Psychiatry 43:114-124
97. White EL (1989) Cortical circuits, synaptic organization of the cerebral cortex structure, function, and theory. Birkhäuser, Boston, Mass.
98. White PF (1982) Comparative evaluation of intravenous agents for rapid sequence induction-thiopental, ketamine, and midazolam. Anesthesiology 57:279-284
99. White PF, Way WL, Trevor AJ (1982) Ketamine its pharmacology and therapeutic uses. Anesthesiology 56:119-136
100. Wilkins AJ, Shallice T, McCarthy R (1987) Frontal lesions and sustained attention. Neuropsychologia 25:359-365
101. Willetts J, Balster RL, Leander JD (1990) The behavioral pharmacology of NMDA receptor antagonists. Trend Pharmacol Sci 11:423-428
102. Winer BJ (1971) Statistical Principles in Experimental Design, 2nd edn. McGraw-Hill, New York
103. Wise R, Chollet F, Hadar U, Friston K, Hoffner E, Frackowiak R (1991) Distribution of cortical neural networks involved in word comprehension and word retrieval. Brain 114:1803-1817
104. Wolkin A, Sanfilipo M, Wolf AP, Angrist B, Brodie JD, Rotrosen J (1992) Negative symptoms and hypofrontality in chronic schizophrenia. Arch Gen Psychiatry 49:959-965
105. Wolkowitz WM, Pickar D (1991) Benzodiazepines in the treatment of schizophrenia : a review and reappraisal. Am J Psychiatry 148:714-726
106. Wood JD, Hertz L (1980) Ketamine-induced changes in the GABA system of mouse brain. Neuropharmacology 19:805-808
107. Yamakura T, Mori H, Masaki H, Shimoji K, Mishma M (1993) Differential sensitivities of NMDA receptor channel subtypes to non-competitive antagonists. Neurorep 4:687-690
108. Zeilhofer HU, Swandulla D, Geisslinger G, Brune K (1992) Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons. Eur J Pharmacol 213:155-158
109. Zsigmond EK, Domino EP (1980) Clinical pharmacology and current uses of ketamine. Trends in Intravenous Anesthesia Aldrite J. Stanley T (eds) Yearbook Medical Publishers, Chicago, IL. pp 283-328